• Anti Reverse Cap Analog for Synthetic mRNA

  2026-08-12

  Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, enables orientation-specific capping for high-output synthetic mRNA workflows. Explore practical IVT setup, LNP-oriented assay design, troubleshooting, and evidence-informed applications in mRNA therapeutics research.

• Acridine Orange hydrochloride: Practical Staining Guide

  2026-08-11

  Acridine Orange hydrochloride is a membrane-permeable fluorescent nucleic acid dye for differentiating green and red signals associated with double-helical and single-stranded nucleic acid staining. This guide covers preparation, flow and microscopy workflow controls, and interpretation boundaries; it is not intended for long-term dye-solution storage or unsupported mechanistic conclusions.

• BODIPY 581/591 C11 for Lipid Peroxidation

  2026-08-11

  Learn how BODIPY 581/591 C11 (SKU C8003) supports ratiometric lipid peroxidation detection, oxidative stress measurement, and antioxidant capacity evaluation in live-cell and membrane assays. Scenario-based guidance covers assay design, protocol handling, data interpretation, and practical vendor-selection criteria.

• 2-NBDG: Fluorescent Glucose Uptake Assays

  2026-08-10

  2-NBDG is a fluorescent glucose uptake tracer for flow cytometry, fluorescence microscopy, and microplate-based glucose metabolism assay workflows. Its signal supports comparative uptake measurements, but cell type, concentration, solubility, and fluorescence-quenching controls determine interpretation.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-09

  FITC-Concanavalin A (ConA) Conjugate, SKU K4413, provides fluorescence-based detection of accessible α-D-glucose and α-D-mannose residues in cell or tissue samples. It is intended for carbohydrate-binding workflows such as immunofluorescence and flow cytometry, not for non-glycan targets or as a universal cell-labeling reagent.

• Candida krusei Phase-Specific Apoptosis in BMECs

  2026-08-08

  Miao and colleagues showed that the yeast and hypha phases of Candida krusei trigger bovine mammary epithelial cell apoptosis through different dominant pathways. The study connects fungal morphology with mitochondrial, death ligand/receptor, TLR2/TLR4, ERK, and JNK responses, providing a mechanistic framework for Candida mastitis research.

• SM-164 Workflow for Apoptosis Research

  2026-08-07

  SM-164 is a bivalent Smac mimetic for resolving how IAP loss, TNFα signaling, and caspase activation shape tumor-cell death. This practical guide covers solvent handling, time-resolved assays, model selection, controls, and interpretation strategies for cancer research.

• Batimastat (BB-94): Transforming MMP Inhibition in Cancer an

  2026-08-07

  Batimastat (BB-94) empowers researchers to precisely dissect matrix metalloproteinase (MMP) function across cancer and neuromuscular synapse models, offering unmatched potency and workflow adaptability. This guide bridges breakthrough mechanistic insight from recent BDNF studies to actionable in vitro and in vivo protocols, troubleshooting, and translational opportunities.

• Bestatin Hydrochloride: Advanced Workflows for Angiogenesis

  2026-08-06

  Bestatin hydrochloride (Ubenimex) offers precise and reproducible inhibition of aminopeptidase N and B, empowering researchers to dissect angiogenesis, tumor invasion, and peptide signaling in both cancer and neuroscience models. This article provides actionable workflow enhancements, troubleshooting insights, and cross-domain applications, all grounded in robust experimental data and the pivotal findings of the reference study.

• Asymmetric Cu Single-Atom Nanozyme Modulates AMI Inflammatio

  2026-08-06

  This study introduces an asymmetrically coordinated copper single-atom nanozyme (Cu-BrN3/SAN@M) that demonstrates superior reactive oxygen species (ROS) scavenging and immune modulation in acute myocardial infarction (AMI) models. The findings point to the potential of rationally engineered nanozymes for targeted oxidative stress mitigation and improved post-infarction outcomes.

• JNK-IN-7: Selective JNK Inhibitor for Advanced Apoptosis Ass

  2026-08-05

  JNK-IN-7, a covalent JNK inhibitor, empowers researchers to precisely dissect MAPK signaling and apoptosis pathways in cell-based models. This article bridges innovative findings from infection biology with practical applications in kinase assay design, offering actionable protocols and troubleshooting tips for robust, reproducible results.

• High Viscosity Drives Chemoresistance via TRPV4-YAP-P-gp Pat

  2026-08-05

  This study reveals that high extracellular fluid viscosity in the tumor microenvironment directly promotes chemoresistance by upregulating P-glycoprotein (P-gp) through the TRPV4-YAP signaling axis. The findings highlight a mechanobiological mechanism for chemoresistance, suggesting that modulating tumor viscosity may enhance chemotherapeutic efficacy.

• Galectin-1 Impairs Autophagy and Drives Hepatic Steatosis vi

  2026-08-04

  This study uncovers galectin-1 as a direct suppressor of hepatic autophagy through its interaction with the scaffold protein FIP200, revealing a mechanistic link to the progression of non-alcoholic fatty liver disease (NAFLD). The findings introduce the Gal-1–FIP200 axis as a novel therapeutic target for metabolic liver disease and provide a framework for investigating autophagy dysregulation in metabolic disorder models.

• Redox-Responsive Peptide Coacervates Advance mRNA Delivery

  2026-08-04

  This study introduces HBpep-SS4, a single-component, redox-sensitive peptide coacervate for efficient mRNA encapsulation and glutathione-triggered cytosolic release. The approach achieves high gene editing efficiency and offers a biocompatible alternative to traditional lipid nanoparticles, with implications for safer, more controllable RNA delivery.

• Tomivosertib (SKU C8762): Reliable MNK1 Inhibition for Cell

  2026-08-03

  Tomivosertib (SKU C8762) is a highly selective MNK1/2 inhibitor that addresses core challenges in cell viability, proliferation, and cytotoxicity assays by providing reproducible, data-driven results. This article offers scenario-based guidance for optimizing experimental design, protocol execution, and product selection in biomedical research, with evidence-backed recommendations and direct links to validated protocols.

8708 records 3/581 page Previous Next 12345 下5页 Last page